A 3.74% rally on a single Friday would normally signal renewed confidence. For IBM, it barely registers as a toehold after the worst trading session in the company’s 113-year history. The stock closed at €188.38, clawing back just enough to sit 7.56% above its 52-week low of €175.14 — a floor touched only four days earlier.
The damage from mid-July remains staggering. IBM’s preliminary second-quarter results missed expectations by a wide margin, triggering a 25% single-day collapse that surpassed even the infamous 1987 crash as the steepest daily loss on record. The shares now trade 35.67% below the year’s peak of €292.85, reached as recently as June 1, and have shed 27.52% since January.
A Technical Bounce, Not a Turnaround
The relative strength index sits at 35.5, still deep in oversold territory despite the Friday pop. The 30-day annualized volatility has surged to nearly 85%, reflecting a market that whipsaws between panic and tentative optimism. The stock is now wedged between its recent low and the 50-day moving average of €228.64 — a level that implies 17.61% upside from Friday’s close. The 100-day average at €217.41 looms as the next meaningful resistance.
But technical markers tell only part of the story. What makes this recovery so hard to gauge is a second, more troubling development that extends beyond a single weak quarter.
The Pipeline Question
IBM is facing a securities investigation into whether it artificially inflated its sales pipeline ahead of the July 14 preliminary announcement. Preliminary inquiries do not equate to guilt, but they shift the debate from a simple earnings miss to a deeper question: was the pipeline ever as robust as management portrayed?
This distinction — timing problem versus structural weakness — will determine whether July’s crash becomes an isolated event or a lasting blow to IBM’s forecasting credibility. CEO Arvind Krishna tried to address the concern directly during the post-earnings conference call, telling investors that a third of the deferred software deals had already returned. “Our AI strategy is the right one for IBM,” he insisted, pointing to hybrid sovereignty and trust as the company’s core differentiators.
Krishna Draws a Line
The CEO also pushed back against breakup speculation that has swirled since the sell-off. IBM’s finance chief reinforced the message, arguing the company is “strongest as an integrated enterprise” with hybrid cloud, AI, and quantum computing as a shared foundation.
Should investors sell immediately? Or is it worth buying IBM?
The guidance revision was modest but telling. IBM now expects constant-currency revenue growth of 4% to 5% for the full year, down from the earlier forecast of “more than 5%.” The culprit is the mainframe business, where customers are diverting capital toward AI infrastructure such as servers and chips. The infrastructure unit fell 7% to $3.84 billion in the second quarter, with Z-mainframe revenue alone plummeting 42%.
Software Carries the Weight
While hardware stumbles, IBM’s high-margin software engine is doing the heavy lifting. The segment generated $7.76 billion in revenue, up 5% year over year. Red Hat grew 11%, and the data business jumped 19%. Consulting held steady at $5.33 billion. Total company revenue came in at roughly $17.2 billion.
Despite the lowered top-line outlook, IBM is standing by its free cash flow target, promising an increase of roughly $1 billion year over year. That commitment may be the single most important anchor for investors trying to assess whether the business is fundamentally intact.
Analysts Divided, Options Priced for Volatility
The analyst community is unusually fractured for a company of IBM’s size. The spread between the most bearish and most bullish price targets is exceptionally wide. Some analysts actually raised their targets on the morning of the 25% crash, betting the market had overreacted. The average price target of €231.06 still implies 22.7% upside from Friday’s close — hardly a vote of no confidence.
Options markets tell a similar story of uncertainty. Premiums remain elevated, signaling that traders expect continued large swings. Stifel analyst David Grossman sees the stock stuck in a sideways-to-slightly-lower range, citing poor near-term visibility and seasonal headwinds. One portfolio manager put it more bluntly to Yahoo Finance, saying IBM has landed “in the penalty box” while it recalibrates its business.
The Real Test Lies Ahead
For a stock that just endured its worst single day in more than a century, one Friday rally is not a turning point — it is a single data point in one of the most turbulent chapters of IBM’s recent history. Whether the securities probe escalates or fizzles will likely matter more for the next leg of the stock than any chart level. And whether Krishna’s confidence in the deal pipeline proves justified will be measured not in daily price moves, but in the quarterly reports to come.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from July 26 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 26.
IBM: Buy or sell? Read more here...
